Campbell & CO Investment Adviser LLC Travere Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$23.61 - $30.6 $172,353 - $223,380
-7,300 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$24.34 - $31.17 $177,682 - $227,541
7,300 New
7,300 $227,000
Q3 2021

Nov 10, 2021
SELL
$12.98 - $25.03 $402,380 - $775,930
-31,000 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$14.11 - $26.4 $437,410 - $818,400
31,000 New
31,000 $452,000

Others Institutions Holding TVTX

# of Institutions
198
Shares Held
84.9M
Call Options Held
776K
Put Options Held
912K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.3B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email